IDenTT Bio is a biotechnology company dedicated to revolutionizing the treatment of cancer and viral infections through innovative therapies that harness the power of monocytes through dendritic cell based platforms. Recognizing the crucial role of immune modulation and inflammation control, IDenTT Bio is developing cutting-edge approaches to target and eradicate cancer cells and combat viral infections by leveraging the unique capabilities of these immune cells.
Our therapeutic strategies aim to create more effective and less toxic treatments for a wide range of cancers and to develop novel anti-viral interventions. We are committed to translating groundbreaking scientific discoveries into tangible clinical benefits for patients.
We bring over 15 years of experience in the biotechnology and pharmaceutical industry, IDenTT Bio benefits from strong expertise in R&D, product development, clinical studies, and CMC/regulatory affairs. The company is actively seeking collaborations and partnerships to accelerate the development and commercialization of its novel therapeutic platforms.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.identtbio.com/
Identt Bio Questions
Identt Bio's website is https://www.identtbio.com/
Identt Bio's LinkedIn profile is https://www.linkedin.com/company/identt-bio
Identt Bio's industry is
Biotechnology Research
Identt Bio's top competitors are
Menow,
Sun Pharma,
Quris Ai,
Orgenesis Inc.,
Lempo Therapeutics Ltd.,
Alvit Lcs Pharma,
Pomicell,
Biokine Therapeutics Ltd..
Identt Bio's categories are Biotechnology Research
